Palantir WKN: A2QA4J ISIN: US69608A1088 Kürzel: PLTR Forum: Aktien User: FromGordonWithLove

Eine beunruhigende Nachricht. Ich habe keine Ahnung, ob es wahr ist. Aber wenn ja, dann riecht es nach Manipulation der Verkaufszahlen: 'That analyst is RBC Capital's Rishi Jaluria, who nearly doubled his fair value estimation of Palantir stock. Just after those earnings were disseminated, he reset his price target to $9 per share from his previous $5. Yet, as the new level is 33% below the company's latest closing price, he left his underperform recommendation intact. Jaluria admitted that the quarterly figures were "decent," yet he stated that growth in the crucial commercial segment was completely due to revenue from a controversial activity -- Palantir's investments in special purpose acquisition companies (SPACs). At least some of the recipients of these investments, according to The Wall Street Journal, simultaneously signed contracts with Palantir. Worryingly, many of these businesses are not doing well. "Our concerns on the sustainability of growth/margins are unchanged, the analyst wrote in his note. "We see the risk-reward skewed negatively with shares trading at a premium multiple." ' https://www.fool.com/investing/2024/05/10/1-wall-street-analyst-sees-9-for-palantir/?source=djc&utm_source=djc&utm_medium=feed&utm_campaign=article&mod=mw_quote_news

Ich würde noch warten, 17,50€ erscheint mir als der richtige Preis.

Hab hier mal mit einer ersten Tranche zugeschlagen

Und dann , verkaufen wenn sich irgendwelche Linien durchkreuzen? Bei den nächsten News bist dann weg vom Fenster . Das ist mehr Stress als alles andere 🤪

Eine beunruhigende Nachricht. Ich habe keine Ahnung, ob es wahr ist. Aber wenn ja, dann riecht es nach Manipulation der Verkaufszahlen: 'That analyst is RBC Capital's Rishi Jaluria, who nearly doubled his fair value estimation of Palantir stock. Just after those earnings were disseminated, he reset his price target to $9 per share from his previous $5. Yet, as the new level is 33% below the company's latest closing price, he left his underperform recommendation intact. Jaluria admitted that the quarterly figures were "decent," yet he stated that growth in the crucial commercial segment was completely due to revenue from a controversial activity -- Palantir's investments in special purpose acquisition companies (SPACs). At least some of the recipients of these investments, according to The Wall Street Journal, simultaneously signed contracts with Palantir. Worryingly, many of these businesses are not doing well. "Our concerns on the sustainability of growth/margins are unchanged, the analyst wrote in his note. "We see the risk-reward skewed negatively with shares trading at a premium multiple." ' https://www.fool.com/investing/2024/05/10/1-wall-street-analyst-sees-9-for-palantir/?source=djc&utm_source=djc&utm_medium=feed&utm_campaign=article&mod=mw_quote_news